Artelo Biosciences Announces Proposed Underwritten Public Offering
Artelo Biosciences Announces Proposed Underwritten Public Offering GlobeNewswire September 03, 2025 SOLANA BEACH, Calif., Sept. 03, 2025 (GLOBE NEWSWIRE) — Artelo Biosciences, Inc. (Nasdaq: ARTL), a clinical-stage pharmaceutical company focused on modulating lipid-signaling pathways to develop treatments for people living with cancer, pain, dermatologic, or neurological conditions, today announced it has commenced an underwritten public […]